A. Degen

696 total citations
9 papers, 446 citations indexed

About

A. Degen is a scholar working on Oncology, Dermatology and Molecular Biology. According to data from OpenAlex, A. Degen has authored 9 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Dermatology and 4 papers in Molecular Biology. Recurrent topics in A. Degen's work include Cutaneous Melanoma Detection and Management (5 papers), Melanoma and MAPK Pathways (4 papers) and Nonmelanoma Skin Cancer Studies (3 papers). A. Degen is often cited by papers focused on Cutaneous Melanoma Detection and Management (5 papers), Melanoma and MAPK Pathways (4 papers) and Nonmelanoma Skin Cancer Studies (3 papers). A. Degen collaborates with scholars based in Germany, United States and Austria. A. Degen's co-authors include Ralf Gutzmer, Alexander Kapp, Imke Satzger, Eggert Stockfleth, Manisha J. Patel, Claas Ulrich, Jürgen Eberle, Wolfram Sterry, Martina Ulrich and Dorothea Terhorst‐Molawi and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and British Journal of Dermatology.

In The Last Decade

A. Degen

9 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Degen Germany	7	277	251	194	99	55	9	446
Liming Wu China	9	73 0.3×	162 0.6×	36 0.2×	161 1.6×	30 0.5×	31	348
Alexa J. Resler United States	9	30 0.1×	126 0.5×	76 0.4×	75 0.8×	30 0.5×	12	323
Petra Cetkovská Czechia	10	174 0.6×	29 0.1×	59 0.3×	30 0.3×	34 0.6×	32	345
S. van Hattem Netherlands	7	256 0.9×	137 0.5×	126 0.6×	43 0.4×	4 0.1×	7	397
Yunwei Han China	11	26 0.1×	135 0.5×	52 0.3×	79 0.8×	70 1.3×	28	331
Karl M. Hoegler United States	6	103 0.4×	36 0.1×	44 0.2×	32 0.3×	9 0.2×	15	244
P. Modiano France	9	64 0.2×	31 0.1×	60 0.3×	29 0.3×	17 0.3×	35	272
Atul Samaiya India	13	23 0.1×	73 0.3×	42 0.2×	338 3.4×	43 0.8×	29	528
Grace A. Hile United States	12	76 0.3×	50 0.2×	60 0.3×	84 0.8×	6 0.1×	22	416
James M. Roseman United States	8	81 0.3×	69 0.3×	26 0.1×	32 0.3×	23 0.4×	14	288

Countries citing papers authored by A. Degen

Since Specialization

Citations

This map shows the geographic impact of A. Degen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Degen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Degen more than expected).

Fields of papers citing papers by A. Degen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Degen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Degen. The network helps show where A. Degen may publish in the future.

Co-authorship network of co-authors of A. Degen

This figure shows the co-authorship network connecting the top 25 collaborators of A. Degen. A scholar is included among the top collaborators of A. Degen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Degen. A. Degen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Degen, A., Michael Weichenthal, Selma Ugurel, et al.. (2013). Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha‐2b in metastatic melanoma (phase II DeCOG trial). JDDG Journal der Deutschen Dermatologischen Gesellschaft. 11(9). 846–853. 9 indexed citations

2.

Satzger, Imke, et al.. (2013). Serious Skin Toxicity With the Combination of BRAF Inhibitors and Radiotherapy. Journal of Clinical Oncology. 31(13). e220–e222. 51 indexed citations

3.

Egberts, Friederike, Ralf Gutzmer, Selma Ugurel, et al.. (2011). Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial. Annals of Oncology. 22(7). 1667–1674. 26 indexed citations

4.

Degen, A., Mareike Alter, Florian Schenck, Alexander Kapp, & Ralf Gutzmer. (2011). Kutane Nebenwirkungen der medikamentösen Tumortherapie. Der Hautarzt. 62(6). 444–451. 2 indexed citations

5.

Degen, A., Mareike Alter, Florian Schenck, et al.. (2010). The hand‐foot‐syndrome associated with medical tumor therapy – classification and management. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 8(9). 652–661. 107 indexed citations

6.

Degen, A., et al.. (2010). Does Basal Cell Carcinoma Belong to the Spectrum of Sorafenib-Induced Epithelial Skin Cancers?. Dermatology. 221(3). 193–196. 17 indexed citations

7.

Degen, A., Mareike Alter, Florian Schenck, et al.. (2010). Das Hand‐Fuß‐Syndrom als Nebenwirkung der medikamentösen Tumortherapie – Klassifikation und Management. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 8(9). 652–662. 9 indexed citations

8.

Ulrich, Claas, Jan Steffen Jürgensen, A. Degen, et al.. (2009). Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. British Journal of Dermatology. 161. 78–84. 224 indexed citations

9.

Ulrich, Claas, A. Degen, Manisha J. Patel, & Eggert Stockfleth. (2008). Sunscreens in organ transplant patients. Nephrology Dialysis Transplantation. 23(8). 2712–2712. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact